Scopus Author Profile
รศ.พญ.สุดา วรรณประสาท
Assoc. Prof. Suda Vannaprasaht
Research Interest :
- Pharmacogenetics
- Clinical Pharmacology
- Clinical Toxicology
Publication (Last 5 years : 2021-2025)
International Publication
- Sanlung T, Sa-Ngiamwibul P, Sookprasert A, Chindaprasirt J, Titapun A, Kongpetch S, Dornsena A, Areesinpitak T, Tassaneeyakul W, Vannaprasaht S, Wirasorn K. Excision Repair Cross-Complementation Group 1 (ERCC1) Polymorphism Predicted Platinum-Based Chemotherapy Treatment Outcome in Cholangiocarcinoma. Journal of the Medical Association of Thailand. 2024 Nov;107(1):S63-70.
- Muengsaen D, Areesinpitak T, Wirasorn K, Tassaneeyakul W, Vannaprasaht S. Prevalence of Cytidine Deaminase and Ribonucleotide Reductase Polymorphism in Thai Healthy Volunteers. Journal of the Medical Association of Thailand. 2024 Nov;107(1):S55-62.
- Khaeso K, Komvilaisak P, Chainansamit SO, Nakkam N, Suwannaying K, Kuwatjanakul P, Hikino K, Dornsena A, Kanjanawart S, Laoaroon N, Vannaprasaht S, Taketani T, Tassaneeyakul W. NUDT15 is a key genetic factor for prediction of hematotoxicity in pediatric patients who received a standard low dosage regimen of 6-mercaptopurine. Drug Metabolism and Pharmacokinetics. 2022 Apr;43: 100436.
- Khaeso K, Nakkam N, Komwilaisak P, Wongmast P, Chainansamit SO, Dornsena A, Kanjanawart S, Vannaprasaht S, Tassaneeyakul W. Genetic Polymorphisms of Drug-Metabolizing Enzymes Involved in 6-Mercaptopurine-Induced Myelosuppression in Thai Pediatric Acute Lymphoblastic Leukemia Patients. J Pediatr Genet. 2021 Mar;10(1):29-34.
- Boonsom S, Vannaprasaht S, Preechagoon Y. Therapeutic dosage ranges and chronic adverse effects of tacrolimus in thai kidney transplant patients. International Journal of Applied Pharmaceutics. 2021 Jan;13(Special Issue 1):13-16.